CXCR3 chemokine receptor contributes to specific CD8(+) T cell activation by pDC during infection with intracellular pathogens

Chemokine receptor type 3 (CXCR3) plays an important role in CD8(+) T cells migration during intracellular infections, such as Trypanosoma cruzi. In addition to chemotaxis, CXCR3 receptor has been described as important to the interaction between antigen-presenting cells and effector cells. We hypothesized that CXCR3 is fundamental to T. cruzi-specific CD8(+) T cell activation, migration and effector function. Anti-CXCR3 neutralizing antibody administration to acutely T. cruzi-infected mice decreased the number of specific CD8(+) T cells in the spleen, and those cells had impaired in activation and cytokine production but unaltered proliferative response. In addition, anti-CXCR3-treated mice showed decreased frequency of CD8(+) T cells in the heart and numbers of plasmacytoid dendritic cells in spleen and lymph node. As CD8(+) T cells interacted with plasmacytoid dendritic cells during infection by T. cruzi, we suggest that anti-CXCR3 treatment lowers the quantity of plasmacytoid dendritic cells, which may contribute to impair the prime of CD8(+) T cells. Understanding which molecules and mechanisms guide CD8(+) T cell activation and migration might be a key to vaccine development against Chagas disease as those cells play an important role in T. cruzi infection control.